These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 25704785)

  • 1. Musculoskeletal simulation can help explain selective muscle degeneration in Duchenne muscular dystrophy.
    Hu X; Blemker SS
    Muscle Nerve; 2015 Aug; 52(2):174-82. PubMed ID: 25704785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative Skeletal Muscle MRI: Part 2, MR Spectroscopy and T2 Relaxation Time Mapping-Comparison Between Boys With Duchenne Muscular Dystrophy and Healthy Boys.
    Kim HK; Serai S; Lindquist D; Merrow AC; Horn PS; Kim DH; Wong BL
    AJR Am J Roentgenol; 2015 Aug; 205(2):W216-23. PubMed ID: 26204310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative Skeletal Muscle MRI: Part 1, Derived T2 Fat Map in Differentiation Between Boys With Duchenne Muscular Dystrophy and Healthy Boys.
    Johnston JH; Kim HK; Merrow AC; Laor T; Serai S; Horn PS; Kim DH; Wong BL
    AJR Am J Roentgenol; 2015 Aug; 205(2):W207-15. PubMed ID: 26204309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantifying disease activity in fatty-infiltrated skeletal muscle by IDEAL-CPMG in Duchenne muscular dystrophy.
    Mankodi A; Bishop CA; Auh S; Newbould RD; Fischbeck KH; Janiczek RL
    Neuromuscul Disord; 2016 Oct; 26(10):650-658. PubMed ID: 27593185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Three-point technique of fat quantification of muscle tissue as a marker of disease progression in Duchenne muscular dystrophy: preliminary study.
    Wren TA; Bluml S; Tseng-Ong L; Gilsanz V
    AJR Am J Roentgenol; 2008 Jan; 190(1):W8-12. PubMed ID: 18094282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progression and variation of fatty infiltration of the thigh muscles in Duchenne muscular dystrophy, a muscle magnetic resonance imaging study.
    Li W; Zheng Y; Zhang W; Wang Z; Xiao J; Yuan Y
    Neuromuscul Disord; 2015 May; 25(5):375-80. PubMed ID: 25701397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exercise and muscular dystrophy: implications and analysis of effects on musculoskeletal and cardiovascular systems.
    Barnabei MS; Martindale JM; Townsend D; Metzger JM
    Compr Physiol; 2011 Jul; 1(3):1353-63. PubMed ID: 23733645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of plantar flexion contracture contribution during the gait of children with Duchenne muscular dystrophy.
    Gaudreault N; Gravel D; Nadeau S
    J Electromyogr Kinesiol; 2009 Jun; 19(3):e180-6. PubMed ID: 17977021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel ex vivo protocol to mimic human walking gait: implications for Duchenne muscular dystrophy.
    Bukovec KE; Hu X; Borkowski M; Jeffery D; Blemker SS; Grange RW
    J Appl Physiol (1985); 2020 Oct; 129(4):779-791. PubMed ID: 32881620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Muscle Eccentric Contractions Increase in Downhill and High-Grade Uphill Walking.
    Hu X; Pickle NT; Grabowski AM; Silverman AK; Blemker SS
    Front Bioeng Biotechnol; 2020; 8():573666. PubMed ID: 33178672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of dixon and T1-weighted MR methods to assess the degree of fat infiltration in duchenne muscular dystrophy patients.
    Wokke BH; Bos C; Reijnierse M; van Rijswijk CS; Eggers H; Webb A; Verschuuren JJ; Kan HE
    J Magn Reson Imaging; 2013 Sep; 38(3):619-24. PubMed ID: 23292884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sodium (23Na) MRI detects elevated muscular sodium concentration in Duchenne muscular dystrophy.
    Weber MA; Nagel AM; Jurkat-Rott K; Lehmann-Horn F
    Neurology; 2011 Dec; 77(23):2017-24. PubMed ID: 22116947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beneficial role of adipose-derived mesenchymal stem cells from microfragmented fat in a murine model of duchenne muscular dystrophy.
    Bouglé A; Rocheteau P; Briand D; Hardy D; Verdonk F; Tremolada C; Hivelin M; Chrétien F
    Muscle Nerve; 2019 Sep; 60(3):328-335. PubMed ID: 31228273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Skeletal muscle water T
    Mankodi A; Azzabou N; Bulea T; Reyngoudt H; Shimellis H; Ren Y; Kim E; Fischbeck KH; Carlier PG
    Neuromuscul Disord; 2017 Aug; 27(8):705-714. PubMed ID: 28601553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated phosphodiester and T
    Hooijmans MT; Niks EH; Burakiewicz J; Verschuuren JJ; Webb AG; Kan HE
    NMR Biomed; 2017 Jan; 30(1):. PubMed ID: 27859827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment with L-citrulline and metformin in Duchenne muscular dystrophy: study protocol for a single-centre, randomised, placebo-controlled trial.
    Hafner P; Bonati U; Rubino D; Gocheva V; Zumbrunn T; Gueven N; Fischer D
    Trials; 2016 Aug; 17(1):389. PubMed ID: 27488051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modeling disease trajectory in Duchenne muscular dystrophy.
    Rooney WD; Berlow YA; Triplett WT; Forbes SC; Willcocks RJ; Wang DJ; Arpan I; Arora H; Senesac C; Lott DJ; Tennekoon G; Finkel R; Russman BS; Finanger EL; Chakraborty S; O'Brien E; Moloney B; Barnard A; Sweeney HL; Daniels MJ; Walter GA; Vandenborne K
    Neurology; 2020 Apr; 94(15):e1622-e1633. PubMed ID: 32184340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative MRI and strength measurements in the assessment of muscle quality in Duchenne muscular dystrophy.
    Wokke BH; van den Bergen JC; Versluis MJ; Niks EH; Milles J; Webb AG; van Zwet EW; Aartsma-Rus A; Verschuuren JJ; Kan HE
    Neuromuscul Disord; 2014 May; 24(5):409-16. PubMed ID: 24613733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longitudinal Evaluation of Muscle Composition Using Magnetic Resonance in 4 Boys With Duchenne Muscular Dystrophy: Case Series.
    Senesac CR; Lott DJ; Forbes SC; Mathur S; Arpan I; Senesac ES; Walter GA; Vandenborne K
    Phys Ther; 2015 Jul; 95(7):978-88. PubMed ID: 25592189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The value of mammalian models for duchenne muscular dystrophy in developing therapeutic strategies.
    Banks GB; Chamberlain JS
    Curr Top Dev Biol; 2008; 84():431-53. PubMed ID: 19186250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.